Tobacco smoke-induced hypercoagulation in human plasma: Role of carbon monoxide

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 4, 2013, Pages 405-410

  Nielsen, Vance G ^a   Hafner, David T ^a   Steinbrenner, Evangelina B ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

carbon monoxide; smoking; thrombelastography; thrombosis

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; FIBRINOGEN; HEME; TOBACCO SMOKE;

ADULT; ARTICLE; BLOOD CLOT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SMOKING; THROMBOELASTOGRAPHY;

ADOLESCENT; ADULT; BLOOD COAGULATION TESTS; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROXYLAMINES; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PLASMA; SMOKING; THROMBELASTOGRAPHY; THROMBOSIS;

EID: 84877691085     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835d5458     Document Type: Article

References (24)

1. Agarwal S. The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999-2004. Angiology 2009;60:335-345.
2. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-189. (Pubitemid 43076437)
3. Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 2010;8:917-932.
4. Oliveria A, Barros H, Maciel HJ, Lopes C. Tobacco smoking and acute myocardial infarction in young adults: a population-based case-control study. Prevent Med 2007;44:311-316. (Pubitemid 46550680)
5. Herman PM, Walsh ME. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health 2011;101:491-496.
6. Lind P, Engstrom G, Stavenow L, Janzon L, Lindgard F, Hedblad B. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol 2004;24:577-582. (Pubitemid 38326156)
7. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004;42:83-92. (Pubitemid 38219919)
8. Ariens RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: relation to sex, age, smoking and hypertension. Arterioscler Thromb Vasc Biol 1999;19:2012-2016. (Pubitemid 29379937)
9. van Wersch JW, Vooijs ME, Ubachs JM. Coagulation factor XIII in pregnant smokers and nonsmokers. Int J Clin Lab Res 1997;27:68-71.
10. Neubauer H, Setiadi P, Pinto A, Gunesdogan B, Meves SH, Borgel J, Mugge A. Upregulation of platelet CD40, CD40 ligand (CD40L) and P-selectin expression in cigarette smokers: a flow cytometry study. Blood Coagul Fibrinolysis 2009;20:694-698.
11. Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 2005;45:589-594. (Pubitemid 40222254)
12. Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, et al. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol 2010;30:75-79.
13. Hedblad B, Ogren M, Engstrom G, Wollmer P, Janzon L. Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis 2005;179:177-183. (Pubitemid 40249801)
14. Hedblad BO, Engstrom G, Janzon E, Berglund G, Janzon L. COHb% as a marker of cardiovascular risk in never smokers: results from a populationbased cohort study. Scand J Public Health 2006;34:609-615. (Pubitemid 44834976)
15. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009;20:377-380.
16. Nielsen VG, Malayaman SN, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity. Blood Coagul Fibrinolysis 2010;21:349-353.
17. Nielsen VG, Kirklin JK, George JF, Messinger JD. Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and factor XIII deficient plasma. Blood Coagul Fibrinolysis 2010;21:101-105.
18. Machovec KA, Ushakumari DS, Welsby IJ, Nielsen VG. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2. Thromb Res 2012;129:793-796.
19. Nielsen VG, Cohen JB, Malayaman SN, Nowak M, Vosseller K. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report. Blood Coagul Fibrinolysis 2011;22:443-447.
20. Nielsen VG, Arkebauer MR, Vosseller K. Redox-based thrombelastographic method to detect carboxyhemefibrinogen mediated hypercoagulability. Blood Coagul Fibrinolysis 2011;22:657-661.
21. Nielsen VG, Chawla N, Mangla D, Gomes SB, Arkebauer MR, Wasko KA, et al. Carbon monoxide releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin treated rabbits. Blood Coagul Fibrinolysis 2011;22:756-759.
22. Benowitz NL, Jacob 3rd P, Herrera B. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther 2006;80:703-714. (Pubitemid 44920221)
23. Cronenberger C, Mould DR, Roething H, Sarkar M. Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers. Br J Clin Pharmacol 2007;65:30-39. (Pubitemid 350265167)
24. Nielsen VG, Audu P, Cankovic L, Lyerly RT III, Steenwyk BL, Armstead VE, Powell G. Qualitative thrombelastographic method of detection of tissue factor in human plasma. Anesth Analg 2007;104:59-64. (Pubitemid 46360420)